Hyperliquid Strategies Inc and Sonnet BioTherapeutics Holdings, Inc. Announce Closing of Business Combination
Trading on The Nasdaq Capital Market under the ticker symbol “PURR”
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 02/04/13 | 3 | Initial statement of beneficial ownership of securities |
|
1 | |
| 01/24/13 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 01/22/13 | 8-K | Current report filing |
|
6 | |
| 01/16/13 | 8-K | Current report filing |
|
6 | |
| 01/14/13 | 8-K | Current report filing |
|
4 | |
| 01/02/13 | 10-Q/A | Quarterly report pursuant to Section 13 or 15(d) |
|
   |
6 |
| 12/31/12 | 8-K | Current report filing |
|
5 | |
| 12/31/12 | 10-Q/A | Quarterly report pursuant to Section 13 or 15(d) |
|
|
6 |
| 12/28/12 | 10-Q/A | Quarterly report pursuant to Section 13 or 15(d) |
|
|
36 |
| 12/28/12 | 10-K/A | Annual report pursuant to Section 13 and 15(d) |
|
|
64 |
